NCT05184712 2026-03-04
Phase 3 Clinical Study of AK112 for NSCLC Patients
Akeso
Phase 3 Active not recruiting
Akeso
Changchun GeneScience Pharmaceutical Co., Ltd.
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Merck Sharp & Dohme LLC
The First Affiliated Hospital of Soochow University